Animal models for studies of genetic neurological disorders

被引:0
|
作者
Suzuki, K [1 ]
机构
[1] Univ N Carolina, Sch Med, Dept Neurol & Psychiat, Ctr Neurosci, Chapel Hill, NC 27599 USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:267 / 283
页数:17
相关论文
共 50 条
  • [1] Animal models of neurological disorders
    Marie-Françoise Chesselet
    [J]. NeuroRX, 2005, 2 (3): : 395 - 395
  • [2] Animal Models of Neurological Disorders
    Marie-Francoise Chesselet
    S. Thomas Carmichael
    [J]. Neurotherapeutics, 2012, 9 : 241 - 244
  • [3] Animal Models of Neurological Disorders
    Chesselet, Marie-Francoise
    Carmichael, S. Thomas
    [J]. NEUROTHERAPEUTICS, 2012, 9 (02) : 241 - 244
  • [4] A New Look at Animal Models of Neurological Disorders
    Marie-Françoise Chesselet
    [J]. Neurotherapeutics, 2023, 20 (1) : 1 - 2
  • [5] A New Look at Animal Models of Neurological Disorders
    Chesselet, Marie-Francoise
    [J]. NEUROTHERAPEUTICS, 2023, 20 (01) : 1 - 2
  • [6] In Vitro Models for Studies of Neurological Disorders
    不详
    [J]. ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2010, 38 (06): : 443 - 444
  • [7] Animal Models of Neurological Disorders: Where Are We Now?
    Panthi, Sandesh
    Ekker, Marc
    [J]. BIOMEDICINES, 2023, 11 (05)
  • [8] Large Animal Models of Neurological Disorders for Gene Therapy
    Gagliardi, Christine
    Bunnell, Bruce A.
    [J]. ILAR JOURNAL, 2009, 50 (02) : 128 - 143
  • [9] Efficacy of BCG vaccine in animal models of neurological disorders
    Cossu, Davide
    Ruberto, Stefano
    Yokoyama, Kazumasa
    Hattori, Nobutaka
    Sechi, Leonardo A.
    [J]. VACCINE, 2022, 40 (03) : 432 - 436
  • [10] Therapeutic Effects of Progesterone in Animal Models of Neurological Disorders
    De Nicola, Alejandro F.
    Coronel, Florencia
    Garay, Laura I.
    Gargiulo-Monachelli, Gisella
    Gonzalez Deniselle, Maria Claudia
    Gonzalez, Susana L.
    Labombarda, Florencia
    Meyer, Maria
    Guennoun, Rachida
    Schumacher, Michael
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2013, 12 (08) : 1205 - 1218